Ensign Peak Advisors
OM icon

Ensign Peak Advisors’s Outset Medical OM Stock Holding History

Ensign Peak Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Sell
526,585
-33,584
-6% -$138K ﹤0.01% 710
2025
Q4 		$2.08M Buy
560,169
+234,082
+72% +$2.01M ﹤0.01% 694
2025
Q3 		$4.6M Buy
326,087
+11,565
+4% +$180K 0.01% 612
2025
Q2 		$6.04M Buy
314,522
+230,065
+272% +$3.59M 0.01% 597
2025
Q1 		$934K Sell
84,457
-1,620
-2% -$19.3K ﹤0.01% 1295
2024
Q4 		$1.43M Sell
86,077
-6,519
-7% -$81.4K ﹤0.01% 1111
2024
Q3 		$940K Sell
92,596
-862
-0.9% -$25.6K ﹤0.01% 1358
2024
Q2 		$5.4M Sell
93,458
-13,493
-13% -$661K 0.01% 603
2024
Q1 		$3.56M Buy
106,951
+82,724
+341% +$4.19M 0.01% 737
2023
Q4 		$1.97M Buy
24,227
+705
+3% +$57.4K ﹤0.01% 920
2023
Q3 		$3.84M Buy
23,522
+5,628
+31% +$1.33M 0.01% 644
2023
Q2 		$5.87M Buy
17,894
+1,116
+7% +$340K 0.01% 542
2023
Q1 		$4.63M Sell
16,778
-10,667
-39% -$3.92M 0.01% 591
2022
Q4 		$10.6M Sell
27,445
-14,396
-34% -$4.06M 0.02% 397
2022
Q3 		$10M Buy
41,841
+951
+2% +$255K 0.02% 377
2022
Q2 		$9.12M Buy
40,890
+34,849
+577% +$15M 0.02% 399
2022
Q1 		$4.11M Sell
6,041
-315
-5% -$190K 0.01% 650
2021
Q4 		$4.39M Buy
6,356
+2,497
+65% +$1.85M 0.01% 705
2021
Q3 		$2.86M Buy
3,859
+407
+12% +$277K 0.01% 910
2021
Q2 		$2.59M Sell
3,452
-301
-8% -$230K 0.01% 974
2021
Q1 		$3.06M Sell
3,753
-264
-7% -$204K 0.01% 851
2020
Q4 		$3.42M Buy
4,017
+3,684
+1,106% +$2.84M 0.01% 767
2020
Q3 		$250K Buy
+333
New +$273K ﹤0.01% 1647

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's OM Position: Q1 2026 in Review

Ensign Peak Advisors reduced its Outset Medical (OM) stake by 6% in Q1 2026, selling an estimated $138K and leaving 526,585 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Ensign Peak Advisors first reported a position in OM in Q3 2020 and has held it in 23 quarters since. The position peaked at $10.6M in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Ensign Peak Advisors held 526,585 shares of Outset Medical worth $2.02M as of Q1 2026.
  • Ensign Peak Advisors sold 33,584 Outset Medical shares in Q1 2026, an estimated $138K.
  • Outset Medical made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #710 holding.
  • Ensign Peak Advisors first reported a position in Outset Medical in Q3 2020 and has held it in 23 quarters since.
  • Ensign Peak Advisors's Outset Medical position peaked at $10.6M in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.